Patent Assignment
Reel/Frame 054075/0085
Assignment of Assignor's Interest
Recorded: 2020-10-16
Pages: 8
Assignor
TABUTEAU, HERRIOT
Executed: 2019-10-02
Assignee
AXOME THERAPEUTICS, INC.
22 CORTLANDT STREET, 16TH FLOOR, NEW YORK, NEW YORK, 10007
Covered Properties
(5)
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Pharmaceutical Compositions Comprising Meloxicam
Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion
Application:
16/931,907 →
Publication:
US 2020/0345663
Pharmaceutical Compositions Comprising Meloxicam
Compositions for Delivery of Reboxetine
Application:
17/064,016 →
Publication:
US 2021/0015823
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Intellectual Property Security Agreement
Sep 25, 2020
From: AXSOME THERAPEUTICS, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 053941/0491 →
Assignment of Assignor's Interest
Oct 12, 2020
From: TABUTEAU, HERRIOT
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 054029/0893 →
Security Interest
May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →
Release of Security Interest
May 22, 2025
From: HERCULES CAPITAL, INC.
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 071337/0004 →